Identification of novel protein targets for modification by 15-deoxy-Δ12/14-prostaglandin J2 in mesangial cells reveals multiple interactions with the cytoskeleton

Journal of the American Society of Nephrology

Volumn 17, Issue 1, 2006, Pages 89-98

  Stamatakis, Konstantinos ^a   Sánchez Gómez, Francisco J ^a   Pérez Sala, Dolores ^a  

^a CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; ACTIN; CYCLOPENTENONE; CYCLOPENTENONE PROSTAGLANDIN; CYSTEINE; HEAT SHOCK PROTEIN; NUCLEOSIDE DIPHOSPHATE KINASE; TROPOMYOSIN; TUBULIN; UNCLASSIFIED DRUG; VIMENTIN;

ANIMAL CELL; ARTICLE; BIOTINYLATION; CELL CULTURE; CONTROLLED STUDY; COVALENT BOND; CYTOSKELETON; DRUG BINDING; DRUG EFFECT; DRUG MECHANISM; GENE EXPRESSION REGULATION; KIDNEY DISEASE; MASS SPECTROMETRY; MESANGIUM CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT; STRESS; TWO DIMENSIONAL ELECTROPHORESIS;

EID: 33645459848     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2005030329     Document Type: Article

References (47)

1. Honn KV, Marnett LJ: Requirement of a reactive alpha, beta-unsaturated carbonyl for inhibition of tumor growth and induction of differentiation by "A" series prostaglandins. Biochem Biophys Res Commun 129: 34-40, 1985
2. Schoonjans K, Staels B, Auwerx J: The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation. Biochim Biophys Acta 1302: 93-109, 1996
3. Schiffrin EL, Amiri F, Benkirane K, Iglarz M, Diep QN: Peroxisome proliferator-activated receptors: Vascular and cardiac effects in hypertension. Hypertension 42: 664-668, 2003
4. Guan Y, Breyer MD: Peroxisome proliferator-activated receptors (PPARs): Novel therapeutic targets in renal disease. Kidney Int 60: 14-30, 2001
5. Chatterjee PK, Patel NS, Cuzzocrea S, Brown PA, Stewart KN, Mota-Filipe H, Britti D, Eberhardt W, Pfeilschifter J, Thiemermann C: The cyclopentenone prostaglandin 15-deoxy-delta12,14-prostaglandin J2 ameliorates ischemic acute renal failure. Cardiovasc Res 61: 630-643, 2004
6. Dugo L, Collin M, Cuzzocrea S, Thiemermann C: 15-Deoxy-prostaglandin J2 reduces multiple organ failure caused by wall-fragment of Gram-positive and Gram-negative bacteria. Eur J Pharmacol 498: 295-301, 2004
7. Zingarelli B, Sheehan M, Hake PW, O'Connor M, Denenberg A, Cook A: Peroxisome proliferator activator receptor-gamma ligands, 15-deoxy-delta12,14- prostaglandin J2 and ciglitazone, reduce systemic inflammation in polymicrobial sepsis by modulation of signal transduction pathways. J Immunol 171: 6827-6837, 2003
8. Sawano H, Haneda M, Sugimoto T, Inoki K, Koya D, Kikkawa R: 15-Deoxy-delta12,14-prostaglandin J2 inhibits IL-1beta-induced cyclooxygenase-2 expression in mesangial cells. Kidney Int 61: 1957-1967, 2002
9. Rovin BH, Lu L, Cosio A: Cyclopentenone prostaglandins inhibit cytokine-induced NF-kappaB activation and chemokine production by human mesangial cells. J Am Soc Nephrol 12: 1659-1667, 2001
10. Sánchez-Gómez FJ, Cernuda-Morollón E, Stamatakis K, Pérez-Sala D: Protein thiol modification by 15-deoxy-delta12,14- prostaglandin J2 addition in mesangial cells: Role in the inhibition of pro-inflammatory genes. Mol Pharmacol 66: 1349-1358, 2004
11. Castrillo A, Diaz-Guerra MJ, Hortelano S, Martin-Sanz P, Bosca L: Inhibition of IkappaB kinase and IkappaB phosphorylation by 15-deoxy-delta12,14- prostaglandin J2 in activated murine macrophages. Mol Cell Biol 20: 1692-1698, 2000
12. Straus DS, Pascual G, Li M, Welch JS, Ricote M, Hsiang CH, Sengchanthalangsy LL, Ghosh G, Glass CK: 15-Deoxy-delta12,14-prostaglandin J2 inhibits multiple steps in the NF-kappaB signaling pathway. Proc Natl Acad Sci U S A 97: 4844-4849, 2000
13. Cernuda-Morollón E, Pineda-Molina E, Cañada FJ, Pérez-Sala D: 15-Deoxy-delta12,14-prostaglandin J2 inhibition of NF-kappaB DNA binding through covalent modification of the p50 subunit. J Biol Chem 276: 35530-35536, 2001
14. Pérez-Sala D, Cernuda-Morollón E, Cañada FJ: Molecular basis for the inhibition of AP-1 DNA binding by 15-deoxy-delta12,14- prostaglandin J2. J Biol Chem 278: 51251-51260, 2003
15. Rovin BH, Wilmer WA, Lu L, Doseff AI, Dixon C, Kotur M, Hilbelink T: 15-Deoxy-delta12,14-prostaglandin J2 regulates mesangial cell proliferation and death. Kidney Int 61: 1293-1302, 2002
16. Santoro MG: Heat shock factors and the control of the stress response. Biochem Pharmacol 59: 55-63, 2000
17. Zhang X, Lu L, Dixon C, Wilmer W, Song H, Chen X, Rovin BH: Stress protein activation by the cyclopentenone prostaglandin 15-deoxy-delta12,14- prostaglandin J2 in human mesangial cells. Kidney Int 65: 798-810, 2004
18. Cernuda-Morollón E, Rodríguez-Pascual F, Klatt P, Lamas S, Pérez-Sala D: PPAR agonists amplify iNOS expression while inhibiting NF-kappaB: Implications for mesangial cell activation by cytokines. J Am Soc Nephrol 13: 2223-2231, 2002
19. Sechi S, Chait BT: Modification of cysteine residues by alkylation. A tool in peptide mapping and protein identification. Anal Chem 70: 5150-5158, 1998
20. Ianaro A, Ialenti A, Maffia P, Di Meglio P, Di Rosa M, Santoro MG: Anti-inflammatory activity of 15-deoxy-delta12,14-PGJ2 and 2-cyclopenten-1-one: Role of the heat shock response. Mol Pharmacol 64: 85-93, 2003
21. Narumiya S, Ohno K, Fukushima M, Fujiwara M: Site and mechanism of growth inhibition by prostaglandins. III. Distribution and binding of prostaglandin A2 and delta12-prostaglandin J2 in nuclei. J Pharmacol Exp Ther 242: 306-311, 1987
22. Yoon M, Moir RD, Prahlad V, Goldman R: Motile properties of vimentin intermediate filament networks in living cells. J Cell Biol 143: 147-157, 1998
23. Rossi A, Kapahi P, Natoli G, Takahashi T, Chen Y, Karin M, Santoro MG: Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase. Nature 403: 103-108, 2000
24. Shibata T, Yamada T, Ishii T, Kumazawa S, Nakamura H, Masutani H, Yodoi J, Uchida K: Thioredoxin as a molecular target of cyclopentenone prostaglandins. J Biol Chem 278: 26046-26054, 2003
25. Moos PJ, Edes K, Cassidy P, Massuda E, Fitzpatrick FA: Electrophilic prostaglandins and lipid aldehydes repress redox-sensitive transcription factors p53 and hypoxia-inducible factor by impairing the selenoprotein thioredoxin reductase. J Biol Chem 278: 745-750, 2003
26. Levonen AL, Landar A, Ramachandran A, Ceaser EK, Dickinson DA, Zanoni G, Morrow JD, Darley-Usmar VM: Cellular mechanisms of redox cell signaling: The role of cysteine modification in controlling antioxidant defenses in response to electrophilic lipid oxidation products. Biochem J 378: 373-382, 2004
27. Itoh K, Mochizuki M, Ishii Y, Ishii T, Shibata T, Kawamoto Y, Kelly V, Sekizawa K, Uchida K, Yamamoto M: Transcription factor Nrf2 regulates inflammation by mediating the effect of 15-deoxy-delta12,14-prostaglandin J2. Mol Cell Biol 24: 36-45, 2004
28. Oliva JL, Pérez-Sala D, Castrillo A, Martínez N, Cañada FJ, Boscá L, Rojas JM: The cyclopentenone 15-deoxy-delta12,14-prostaglandin J2 binds to and activates H-Ras. Proc Natl Acad Sci U S A 100: 4772-4777, 2003
29. Shiraki T, Kamiya N, Shiki S, Kodama TS, Kakizuka A, Jingami H: alpha,beta-Unsaturated ketone is a core moiety of natural ligands for covalent binding to peroxisome proliferator-activated receptor. J Biol Chem 280: 14145-14153, 2005
30. Chiosis G, Vilenchik M, Kim J, Solit D: Hsp90: The vulnerable chaperone. Drug Discov Today 9: 881-888, 2004
31. Eaton P, Jones ME, McGregor E, Dunn MJ, Leeds N, Byers HL, Leung KY, Ward MA, Pratt JR, Shattock MJ: Reversible cysteine-targeted oxidation of proteins during renal oxidative stress. J Am Soc Nephrol 14: S290-S296, 2003
32. Nardai G, Sass B, Eber J, Orosz G, Csermely P: Reactive cysteines of the 90-kDa heat shock protein, Hsp90. Arch Biochem Biophys 384: 59-67, 2000
33. Martinez-Ruiz A, Villanueva L, Gonzalez de Orduna C, Lopez-Ferrer D, Higueras MA, Tarin C, Rodriguez-Crespo I, Vazquez J, Lamas S: S-nitrosylation of Hsp90 promotes the inhibition of its ATPase and endothelial nitric oxide synthase regulatory activities. Proc Natl Acad Sci U S A 102: 8525-8530, 2005
34. Song EJ, Kimn YS, Chung JY, Kim E, Chae SK, Lee KJ: Oxidative modification of nucleoside diphosphate kinase and its identification by matrix-assisted laser desorption/ ionization time-of-flight mass spectrometry. Biochemistry 39: 10090-10097, 2000
35. Eaton P, Byers HL, Leeds N, Ward MA, Shattock MJ: Detection, quantitation, purification, and identification of cardiac proteins S-thiolated during ischemia and reperfusion. J Biol Chem 277: 9806-9811, 2002
36. Cumming RC, Andon NL, Haynes PA, Park M, Fischer WH, Schubert D: Protein disulfide bond formation in the cytoplasm during oxidative stress. J Biol Chem 279: 21749-21758, 2004
37. Subhi AL, Diegelman P, Porter CW, Tang B, Lu ZJ, Markham GD, Kruger WD: Methylthioadenosine phosphorylase regulates ornithine decarboxylase by production of downstream metabolites. J Biol Chem 278: 49868-49873, 2003
38. Della Ragione F, Carteni-Farina M, Gragnaniello V, Schettino MI, Zappia V: Purification and characterization of 5′-deoxy-5′- methylthioadenosine phosphorylase from human placenta. J Biol Chem 261: 12324-12329, 1986
39. Collier NC, Sheetz MP, Schlesinger MJ: Concomitant changes in mitochondria and intermediate filaments during heat shock and recovery of chicken embryo fibroblasts. J Cell Biochem 52: 297-307, 1993
40. Lee S-Y, Song EJ, Kim H-J, Kang H-J, Kim J-H, Lee K-J: Rac1 regulates heat shock responses by reorganization of vimentin filaments: Identification using MALDI-TOF MS. Cell Death Differ 8: 1093-1102, 2001
41. Fratelli M, Demol H, Puype M, Casagrande S, Eberini I, Salmona M, Bonetto V, Mengozzi M, Duffieux F, Miclet E, Bachi A, Vandekerckhove J, Gianazza E, Ghezzi P: Identification by redox proteomics of glutathionylated proteins in oxidatively stressed human T lymphocytes. Proc Natl Acad Sci U S A 99: 3505-3510, 2002
42. Landino LM, Moynihan KL, Todd JV, Kennett KL: Modulation of the redox state of tubulin by the glutathione/ glutaredoxin reductase system. Biochem Biophys Res Commun 314: 555-560, 2004
43. Shan B, Medina JC, Santha E, Frankmoelle WP, Chou TC, Learned RM, Narbut MR, Stott D, Wu P, Jaen JC, Rosen T, Timmermans PB, Beckmann H: Selective, covalent modification of beta-tubulin residue Cys-239 by T138067, an antitumor agent with in vivo efficacy against multidrug-resistant tumors. Proc Natl Acad Sci U S A 96: 5686-5691, 1999
44. Legault J, Gaulin JF, Mounetou E, Bolduc S, Lacroix J, Poyet P, Gaudreault RC: Microtubule disruption induced in vivo by alkylation of beta-tubulin by 1-aryl-3-(2-chloroethyl)ureas, a novel class of soft alkylating agents. Cancer Res 60: 985-992, 2000
45. Hata AN, Zent R, Breyer MD, Breyer RM: Expression and molecular pharmacology of the mouse CRTH2 receptor. J Pharmacol Exp Ther 306: 463-470, 2003
46. Chen Y, Morrow JD, Roberts LJ 2nd: Formation of reactive cyclopentenone compounds in vivo as products of the isoprostane pathway. J Biol Chem 274: 10863-10868, 1999
47. Watson AD, Leitinger N, Navab M, Faull KF, Horkko S, Witztum JL, Palinski W, Schwenke D, Salomon RG, Sha W, Subbanagounder G, Fogelman AM, Berliner JA: Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo. J Biol Chem 272: 13597-13607, 1997